Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Vyant Bio Inc (VYNT)

Vyant Bio Inc (VYNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Wall Street - New York Stock Exchange NYSE
Pre-Market Brief: Stocks Mixed After FOMC Minutes Temper Policy Pivot Hopes Barchart - Thu Jan 5, 2023

March S&P 500 futures (ESH23) are trending down -0.07% this morning after three major U.S. benchmark indices finished higher in volatile trading on Wednesday as investors digested the release of the Federal...

ESH23 : 3,957.05s (-0.09%)
NXT.LN : 8,890.000 (-0.56%)
VYNT : 0.1940 (+7.78%)
GERN : 4.66 (+1.30%)
AMZN : 183.29 (+0.09%)
SLP : 39.10 (-1.11%)
LAZR : 1.7000 (+1.80%)
TMUS : 179.23 (-1.55%)
Vyant Bio Announces Investor Conference Call and Webcast for the Second Quarter and First Half of 2022 Globe Newswire - Thu Aug 11, 2022

CHERRY HILL, N.J., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT) is an innovative biotechnology company...

VYNT : 0.1940 (+7.78%)
Vyant Bio Retains Skyline Corporate Communications Group, LLC to Provide Investor Relations Services Globe Newswire - Wed Jun 1, 2022

CHERRY HILL, N.J., June 01, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT) is an innovative biotechnology company...

VYNT : 0.1940 (+7.78%)
Vyant Bio Reports First Quarter 2022 Results and Provides Strategic and Business Highlights Globe Newswire - Mon May 16, 2022

Conference Call and Webcast Today at 4:30 pm ET Scientific and Business Highlights  ●Progress in the discovery of small molecule therapeutics to...

VYNT : 0.1940 (+7.78%)
Vyant Bio Announces Investor Conference Call and Webcast for the First Quarter 2022 Globe Newswire - Tue May 10, 2022

CHERRY HILL, N.J., May 10, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT) is an innovative biotechnology company...

VYNT : 0.1940 (+7.78%)
Vyant Bio Announces Participation in BioNJ’s 12th Annual BioPartnering Conference Globe Newswire - Thu May 5, 2022

CHERRY HILL, N.J., May 05, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), an innovative biotechnology company...

VYNT : 0.1940 (+7.78%)
Vyant Bio Reports Fourth Quarter and Year-End 2021 Results and Provides Strategic and Business Highlights Globe Newswire - Wed Mar 30, 2022

Highlights Focused as a pure-play drug discovery and development biotechnology companyPrimary work on the discovery of small molecule therapeutics to...

VYNT : 0.1940 (+7.78%)
Vyant Bio and OrganoTherapeutics Announce Strategic Collaboration to Discover Therapeutics to Treat Parkinson’s Disease Globe Newswire - Tue Mar 29, 2022

Cherry Hill, N.J. and Esch-sur-Alzette, Luxembourg, March 29, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), an...

VYNT : 0.1940 (+7.78%)
Vyant Bio Announces Investor Conference Call and Webcast for the Year-End 2021 Globe Newswire - Mon Mar 28, 2022

CHERRY HILL, N.J., March 28, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), is an innovative biotechnology company...

VYNT : 0.1940 (+7.78%)
Vyant Bio Issues Letter to Shareholders Globe Newswire - Tue Mar 1, 2022

Cherry Hill, NJ, March 01, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, the “Company”) (Nadsaq:VYNT), is an innovative biotechnology company...

VYNT : 0.1940 (+7.78%)

Barchart Exclusives

Up 121% Since May, What's Behind the Surge in this Penny Stock? Barchart - 1 hour ago
BuzzFeed is a beaten-down tech stock that has gained traction in recent months as several high-profile investors have taken a stake in the media company. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot